Tag: OVER
Naloxone Access Not Linked to Teen Substance Use
Naloxone access and pharmacy naloxone distribution not tied to more adolescent heroin, injection drug use
1999 to 2021 Saw 50-Fold Increase in Methamphetamine Mortality
Proportion of deaths co-involving methamphetamine and heroin or fentanyl peaked at 61.2 percent in 2021
FDA Panel Says Opioid Overdose Antidote Safe to Sell Over the Counter
FDA advisers voted unanimously in favor of making the drug easier to access
FDA Panel Considers Making Opioid Overdose Antidote More Easily Obtainable
Naloxone nasal spray can already be obtained without a prescription, but currently, buyers must get it from a pharmacist
No Increase Seen in OD Deaths Involving Buprenorphine During COVID-19
Proportion of overdose deaths did not increase in association with actions taken to ease access to buprenorphine
Overdose Deaths Up in Teens From July to December 2019 to 2021
About 90 and 83.9 percent of overdose deaths involved opioids and illicitly manufactured fentanyls
Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes
More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone
Self-Service Vending Machine Provides Harm Reduction Services
Vending machine dispenses naloxone, sharps containers, safer injection/smoking kits, pregnancy tests, HIV tests
Discontinuing Long-Term Opioids Tied to Overdose Risk
Tapering cuts risk for overdose among those with opioid use disorder
Increase in Overdose Mortality Greater Among the Pregnant in 2020
Overdose mortality increased about 81 percent from 2017 to 2020 among pregnant and postpartum women
